Search research articles
Contact Us
Filters
Showing results (41-50 of 172) with videos related to
Page
of 18
Sort By:
Diagnostic Microbiology and Infectious Disease
|
November 15, 2011
Telavancin activity tested against a contemporary collection of Gram-positive pathogens from USA Hospitals (2007-2009)
Rodrigo E Mendes, Helio S Sader, David J Farrell, et al.
Diagnostic Microbiology and Infectious Disease
|
August 20, 2011
Update on the telavancin activity tested against European staphylococcal clinical isolates (2009-2010)
Rodrigo E Mendes, Helio S Sader, David J Farrell, et al.
The Journal of Infection
|
May 1, 2014
Ceftolozane/tazobactam activity tested against aerobic Gram-negative organisms isolated from intra-abdominal and urinary tract infections in European and United States hospitals (2012)
Helio S Sader, David J Farrell, Robert K Flamm, et al.
Antimicrobial Agents and Chemotherapy
|
February 12, 2014
Antimicrobial activity of ceftaroline tested against drug-resistant subsets of Streptococcus pneumoniae from U.S. medical centers
Robert K Flamm, Helio S Sader, David J Farrell, et al.
Diagnostic Microbiology and Infectious Disease
|
July 24, 2012
Macrolide and tetracycline resistance among Moraxella catarrhalis isolates from 2009 to 2011
Robert K Flamm, Helio S Sader, David J Farrell, et al.
Antimicrobial Agents and Chemotherapy
|
February 16, 2011
Antimicrobial activity of CXA-101, a novel cephalosporin tested in combination with tazobactam against Enterobacteriaceae, Pseudomonas aeruginosa, and Bacteroides fragilis strains having various resistance phenotypes
Helio S Sader, Paul R Rhomberg, David J Farrell, et al.
Journal of Global Antimicrobial Resistance
|
November 23, 2016
Analysis of 5-year trends in daptomycin activity tested against Staphylococcus aureus and enterococci from European and US hospitals (2009-2013)
Helio S Sader, David J Farrell, Robert K Flamm, et al.
Diagnostic Microbiology and Infectious Disease
|
February 18, 2014
Antimicrobial activity of ceftaroline combined with avibactam tested against bacterial organisms isolated from acute bacterial skin and skin structure infections in United States medical centers (2010-2012)
Robert K Flamm, David J Farrell, Helio S Sader, et al.
International Journal of Antimicrobial Agents
|
March 18, 2014
Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalised with pneumonia in US and European hospitals: results from the SENTRY Antimicrobial Surveillance Program, 2009-2012
Helio S Sader, David J Farrell, Robert K Flamm, et al.
The Journal of Antimicrobial Chemotherapy
|
February 25, 2014
Ceftazidime/avibactam activity tested against Gram-negative bacteria isolated from bloodstream, pneumonia, intra-abdominal and urinary tract infections in US medical centres (2012)
Robert K Flamm, David J Farrell, Helio S Sader, et al.
Page
of 18
Search research articles
Search
Showing results (41-50 of 172) with videos related to
Sort By:
Page
of 18
Diagnostic Microbiology and Infectious Disease
|
November 15, 2011
Telavancin activity tested against a contemporary collection of Gram-positive pathogens from USA Hospitals (2007-2009)
Rodrigo E Mendes, Helio S Sader, David J Farrell, et al.
Diagnostic Microbiology and Infectious Disease
|
August 20, 2011
Update on the telavancin activity tested against European staphylococcal clinical isolates (2009-2010)
Rodrigo E Mendes, Helio S Sader, David J Farrell, et al.
The Journal of Infection
|
May 1, 2014
Ceftolozane/tazobactam activity tested against aerobic Gram-negative organisms isolated from intra-abdominal and urinary tract infections in European and United States hospitals (2012)
Helio S Sader, David J Farrell, Robert K Flamm, et al.
Antimicrobial Agents and Chemotherapy
|
February 12, 2014
Antimicrobial activity of ceftaroline tested against drug-resistant subsets of Streptococcus pneumoniae from U.S. medical centers
Robert K Flamm, Helio S Sader, David J Farrell, et al.
Diagnostic Microbiology and Infectious Disease
|
July 24, 2012
Macrolide and tetracycline resistance among Moraxella catarrhalis isolates from 2009 to 2011
Robert K Flamm, Helio S Sader, David J Farrell, et al.
Antimicrobial Agents and Chemotherapy
|
February 16, 2011
Antimicrobial activity of CXA-101, a novel cephalosporin tested in combination with tazobactam against Enterobacteriaceae, Pseudomonas aeruginosa, and Bacteroides fragilis strains having various resistance phenotypes
Helio S Sader, Paul R Rhomberg, David J Farrell, et al.
Journal of Global Antimicrobial Resistance
|
November 23, 2016
Analysis of 5-year trends in daptomycin activity tested against Staphylococcus aureus and enterococci from European and US hospitals (2009-2013)
Helio S Sader, David J Farrell, Robert K Flamm, et al.
Diagnostic Microbiology and Infectious Disease
|
February 18, 2014
Antimicrobial activity of ceftaroline combined with avibactam tested against bacterial organisms isolated from acute bacterial skin and skin structure infections in United States medical centers (2010-2012)
Robert K Flamm, David J Farrell, Helio S Sader, et al.
International Journal of Antimicrobial Agents
|
March 18, 2014
Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalised with pneumonia in US and European hospitals: results from the SENTRY Antimicrobial Surveillance Program, 2009-2012
Helio S Sader, David J Farrell, Robert K Flamm, et al.
The Journal of Antimicrobial Chemotherapy
|
February 25, 2014
Ceftazidime/avibactam activity tested against Gram-negative bacteria isolated from bloodstream, pneumonia, intra-abdominal and urinary tract infections in US medical centres (2012)
Robert K Flamm, David J Farrell, Helio S Sader, et al.
Page
of 18